Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care

Autologous cell therapy manufacturing timeframes constitute bottlenecks in clinical management pathways of severe burn patients. While effective temporary wound coverings exist for high-TBSA burns, any means to shorten the time-to-treatment with cytotherapeutic skin grafts could provide substantial...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xi, Laurent, Alexis, Liao, Zhifeng, Jaccoud, Sandra, Abdel-Sayed, Philippe, Flahaut, Marjorie, Scaletta, Corinne, Raffoul, Wassim, Applegate, Lee Ann, Hirt-Burri, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536166/
https://www.ncbi.nlm.nih.gov/pubmed/37765300
http://dx.doi.org/10.3390/pharmaceutics15092334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536166/
https://www.ncbi.nlm.nih.gov/pubmed/37765300
http://dx.doi.org/10.3390/pharmaceutics15092334

Ejemplares similares